Broberg, Agneta Månsson
Geisler, Jürgen
Tuohinen, Suvi
Skytta, Tanja
Hrafnkelsdóttir, Þórdís Jóna
Nielsen, Kirsten Melgaard
Hedayati, Elham
Omland, Torbjørn
Offersen, Birgitte V.
Lyon, Alexander R.
Gulati, Geeta http://orcid.org/0000-0002-1316-8676
Funding for this research was provided by:
University of Oslo
Article History
Accepted: 8 September 2020
First Online: 26 September 2020
Compliance with Ethical Standards
:
: ARL has received speaker, advisory board or consultancy fees, and/or research grants from Pfizer, Novartis, Servier, Amgen, Takeda, Roche, Janssens-Cilag Ltd., Clinigen Group, Eli Lily, Eisai, Bristol Myers Squibb, Ferring Pharmaceuticals, Boehringer Ingelheim, Myocardial Solutions, Brainstorm Inc., iOWNA, and Heartfelt Technologies. All the author co-authors have no disclosures. GG has received speaker honoraria from Novartis, AstraZeneca, and Bristol-Myers Squibb. JG has received speaker, advisory board, and consultancy fees from Novartis, AstraZeneca, Pfizer, MSD, BMS, Lilly, and Pierre Fabre. TO reports research support via Akershus University Hospital from Abbott Diagnostics, Novartis, Roche Diagnostics, Singulex, and SomaLogic and honoraria from Siemens Healthineers, Abbott Diagnostics, Roche Diagnostics, and CardiNor. AMB, ST, TS, TJH, KMN, EH, and BVO have no disclosures.
: This article does not contain any studies with human or animal subjects performed by any of the authors.